Pneumococcal Vaccine

What is Pneumococcus?

Pneumococcus (Streptococcus pneumoniae) can cause a range of illnesses. In mild cases, it may lead to sinusitis or ear infections, but it can also result in serious and potentially life‐threatening conditions such as pneumonia, sepsis, and meningitis. Transmission occurs mainly through droplets (coughing or sneezing), close contact with infected individuals, or touching contaminated surfaces. 

Pneumococcal Vaccines stimulate the immune system to produce antibodies against multiple serotypes, helping to prevent pneumonia and invasive infections. Infants and older adults are at greater risk of severe disease and complications, making vaccination one of the effective way to reduce infection and its serious consequences.

Who Should Receive Pneumococcal Vaccines?

  • Infants and young children
  • Adults aged 50 years and above
  • High‐risk groups

Who Is Considered High‐risk?

  • Past serious pneumococcal infection, fluid leak around brain, or cochlear implant
  • Heart disease (not simple high blood pressure), lung, liver or kidney disease
  • Diabetes or obesity (BMI ≥30)
  • Immunocompromised  (splenectomy, HIV/AIDS, cancer, long‑term steroids)
  • Neurological disease affecting breathing, swallowing, or self‑care
Which Pneumococcal Vaccine Is Suitable?
 

15‐valent Conjugate Vaccine (Vaxneuvance)

20‐valent Conjugate Vaccine (Prevnar 20)

23‐valent Polysaccharide Vaccine (Pneumovax 23)

Serotypes covered1、3、4、5、6A、6B、7F、9V、14、18C、19A、19F、22F、23F、33F1、3、4、5、6A、6B、7F、8、9V、10A、11A、12F、14、15B、18C、19A、19F、22F、23F、33F1、2、3、4、5、6B、7F、8、9N、9V、10A、11A、12F、14、15B、17F、18C、19A、19F、20、22F、23F、33F
Target groups
  • Children under 2 years (per Hong Kong Childhood Immunisation Programme)
  • High‐risk individuals aged 2 years or above
  • Infants from 6 weeks
  • Adults aged 18 years or above
  • High‐risk individuals aged 2 years or above
Dosage
  • Children under 2 years: 3 doses (at 2 months, 4 months, and a booster at 12 months)
  • High‐risk individuals above 2 years: 1 dose, followed by PPSV23 after 1 year
  • Infants from 6 weeks to 15 months: 4 doses (at 2 months, 4 months, 6 months, and a booster at 12–15 months)
  • Adults aged 18 years or above: 1 dose
  • 1 dose

Prior to receiving any pneumococcal vaccine, a medical assessment should be conducted to determine the most appropriate option. For further information, please consult our staff at the time of booking.

Frequently Asked Questions (FAQs)
Service Locations

If you have any enquiries about our packages, please feel free to contact our healthcare team through the channel listed below for more details about the service.

Icon Back To Top